Article

Eyetech deal gives quick access to new research

New York-Eyetech Pharmaceuticals and Archemix Corp. will collaborate on the research and development of aptamers for use in the treatment of ophthalmic diseases.

Related Videos
Ophthalmology Times: Kathryn Colby, MD, PhD, reflects on National Women Physicians Day
2 experts are featured in this series.
2 experts are featured in this series.
2 experts are featured in this series.
2 experts are featured in this series.
2 experts are featured in this series.
2 experts are featured in this series.
© 2025 MJH Life Sciences

All rights reserved.